How to Get AndroGel in Ohio: Prescriptions, Telehealth, and Pharmacies

At a glance
- Drug / AndroGel (testosterone gel 1% and 1.62%), FDA-approved for male hypogonadism
- Telehealth prescribing in Ohio / Legal, full audio-video consultations permitted
- Prescribers / MDs, DOs, NPs, and PAs may all prescribe in Ohio
- Compounding access / 503A pharmacies licensed in Ohio may dispense compounded testosterone gel
- Ohio Medicaid coverage / Not covered for male hypogonadism; commercial insurance PA often required
- Key lab requirement / Two morning total testosterone readings below 300 ng/dL
- Typical starting dose / AndroGel 1.62%: 40.5 mg (2 pumps) applied once daily to shoulders/upper arms
- Time to first dose / 5 to 10 business days from initial consultation to pharmacy pickup or shipment
What Is AndroGel and Why Do Ohio Men Need a Prescription for It?
AndroGel is a controlled substance (Schedule III) under the Controlled Substances Act, so no path exists to obtain it without a prescription from a licensed prescriber. The FDA approved testosterone gel 1% (AndroGel) in 2000 and testosterone gel 1.62% (AndroGel 1.62%) in 2011, both manufactured by AbbVie, specifically for adult males with primary or hypogonadotropic hypogonadism confirmed by clinical and laboratory findings. 1
Hypogonadism is more common than many physicians once assumed. The European Male Ageing Study (N=3,369) found that symptomatic late-onset hypogonadism, defined by three sexual symptoms plus a total testosterone below 11 nmol/L (317 ng/dL), affected approximately 2.1% of men aged 40 to 79. 2 The T-Trials, a coordinated set of seven placebo-controlled trials in 788 men aged 65 and older with low testosterone, showed that testosterone treatment improved sexual function, physical performance, and bone mineral density compared with placebo. 3 Those findings provide much of the clinical rationale that prescribers in Ohio use when initiating therapy.
Testosterone is classified as a Schedule III controlled substance under 21 U.S.C. §812, which means Ohio pharmacies must dispense it against a valid prescription and must verify prescriber DEA registration. 4
Step 1: Confirm You Have Low Testosterone with Correct Lab Testing
Before any Ohio prescriber can legally initiate AndroGel, you need documented biochemical evidence of low testosterone. The Endocrine Society's 2018 clinical practice guideline recommends measuring total testosterone on at least two separate morning occasions (7:00 a.m. to 10:00 a.m.) before diagnosis. 5
The guideline states: "We recommend against making a diagnosis of androgen deficiency in men with consistent symptoms and signs in the absence of unequivocally and repeatedly low serum testosterone concentrations." 5
A complete pre-treatment lab panel for an Ohio patient typically includes:
- Total testosterone (two morning draws, at least one day apart)
- Free testosterone (by equilibrium dialysis, not calculated formula, for borderline cases)
- LH and FSH (to distinguish primary from secondary hypogonadism)
- Complete blood count (CBC) with hematocrit (baseline before therapy that raises red-cell mass)
- PSA (prostate-specific antigen) for men 40 and older
- Estradiol (sensitive assay)
- Comprehensive metabolic panel
- Prolactin (when secondary hypogonadism is suspected)
Most telehealth TRT platforms operating in Ohio partner with national lab networks such as LabCorp or Quest Diagnostics, meaning you can walk into a draw site near Columbus, Cleveland, Cincinnati, or any rural Ohio county without a separate physician referral. Results typically return in 24 to 72 hours. 6
Step 2: See a Prescriber, In-Person or via Ohio Telehealth
Ohio fully permits telehealth prescribing of controlled substances for established patient-provider relationships that meet federal Ryan Haight Act requirements. Ohio Revised Code §4743.09 and the Ohio State Medical Board's telehealth rules (effective September 2022) allow audio-video consultations to satisfy the prescribing evaluation requirement for new patients in many clinical situations. 7
For a testosterone prescription specifically, federal DEA regulations require at least one in-person evaluation before a Schedule III controlled substance is prescribed via telemedicine unless the provider qualifies under a DEA telemedicine special registration or a declared public health emergency exception. Confirm with your chosen platform whether they fulfill this requirement through an in-person partner clinic or a DEA special registration. 8
Who can prescribe in Ohio. MDs and DOs with a valid Ohio Medical Board license and DEA registration may prescribe. Advanced practice registered nurses (APRNs) with prescriptive authority and a valid DEA number may also prescribe Schedule III substances in Ohio under Ohio Revised Code §4723.481. Physician assistants (PAs) in Ohio may prescribe Schedule III controlled substances under a supervision agreement with a supervising physician per Ohio Revised Code §4730.10. 9
Step 3: Understand the AndroGel Dosing Protocol
The FDA-approved starting dose of AndroGel 1.62% is 40.5 mg (two pump actuations) applied once daily to the upper arms and shoulders. The prescriber may adjust to 20.25 mg (one pump) or up to 81 mg (four pumps) based on serum testosterone measured 14 days after starting or after each dose change, with the sample drawn two hours after application. 1
For AndroGel 1%, the starting dose is 50 mg (five pump actuations or four packets) applied once daily. Dose adjustments occur at day 14 and day 28. 1
Key application rules the FDA label specifies:
- Apply only to clean, dry, intact skin on shoulders and upper arms (1.62%) or shoulders, upper arms, and abdomen (1%).
- Wash hands immediately after application.
- Cover the application site with clothing after the gel dries to prevent transfer to women or children. Accidental transfer is the most common serious adverse event reported in spontaneous pharmacovigilance; the FDA issued a Black Box Warning for this risk in 2009. 1
- Do not apply to the genitals or the abdomen (for 1.62%).
Testosterone gel produces steadier serum levels than weekly intramuscular injections of testosterone cypionate. A pharmacokinetic study in the AndroGel NDA package showed that once-daily application of 100 mg testosterone gel maintained mean Cavg values within the normal adult male reference range (300 to 1 to 000 ng/dL) over a 24-hour period after day 30 of use. 1
Step 4: Fill Your Prescription at an Ohio Pharmacy or Through Mail Order
Brand-name AndroGel at Ohio retail pharmacies
AndroGel is stocked at most major Ohio pharmacy chains, including CVS, Walgreens, Kroger Pharmacy, and Marc's. The cash price for a 30-day supply of AndroGel 1.62% (75 g pump) ranges from $450 to $650 without insurance. AbbVie's myAbbVie Assist program offers co-pay cards that can reduce out-of-pocket costs to as low as $0 per month for commercially insured patients who qualify. 10
Commercial insurance and prior authorization
Most Ohio commercial insurers, including Anthem, Medical Mutual, and SummaCare, require prior authorization (PA) before covering AndroGel. Standard PA documentation includes:
- Two morning testosterone lab values below the insurer's threshold (typically 300 ng/dL)
- Documentation of symptoms consistent with hypogonadism
- Failure or contraindication to a preferred generic testosterone product in some formularies
- Prescriber's attestation that the patient is not using androgens for performance enhancement
The American Urological Association's white paper on testosterone therapy notes that PA processes vary widely by payer and that denials commonly result from missing symptom documentation rather than failed lab criteria. 11
Ohio Medicaid
Ohio Medicaid does not cover AndroGel or other testosterone products for male hypogonadism. Coverage exists only for type 2 diabetes under certain drug categories. Medicaid-enrolled patients in Ohio must either pay cash, use a manufacturer assistance program, or explore 503A compounded testosterone gel. 12
503A compounding pharmacies in Ohio
Ohio-licensed 503A compounding pharmacies may prepare testosterone gel in concentrations not commercially available (for example, 2% or 10% testosterone gel) for individual patient prescriptions. These compounds require a valid prescription, are not FDA-approved finished products, and cannot be sold wholesale. The Ohio State Board of Pharmacy maintains a public database of licensed compounders. 13
Compounded testosterone gel can significantly reduce cost, with 30-day supplies at some Ohio 503A pharmacies ranging from $60 to $120 for a testosterone 10% topical gel providing equivalent daily androgen exposure to brand AndroGel at a fraction of the price.
Step 5: Monitor Safely and Adjust Therapy Over Time
Starting AndroGel is the beginning of an ongoing clinical relationship, not a one-time transaction. The Endocrine Society guideline recommends follow-up testosterone measurements at 3 months, 6 months, and then annually. Hematocrit should be checked at the same intervals because testosterone therapy raises erythropoiesis; a hematocrit above 54% warrants dose reduction or temporary discontinuation. 5
PSA should be rechecked at 3 to 6 months, then per age-appropriate prostate cancer screening guidelines. Testosterone therapy is contraindicated in men with known or suspected prostate cancer, breast cancer, an untreated severe obstructive sleep apnea, or a baseline hematocrit above 50%. 5
The T-Trials investigators, writing in the New England Journal of Medicine (2016), found that testosterone treatment in older hypogonadal men increased lumbar spine bone mineral density (estimated treatment effect: 7.5%, 95% CI 4.9 to 10.1, P<0.001) over 12 months, but also produced a modest increase in noncalcified coronary artery plaque volume compared with placebo. 3 That cardiovascular signal means cardiovascular risk factors should be reviewed at every follow-up visit.
Fertility preservation is a separate concern. Exogenous testosterone suppresses LH and FSH, reducing intratesticular testosterone and spermatogenesis. Men who want to preserve fertility should discuss alternatives such as clomiphene citrate (off-label) or human chorionic gonadotropin (hCG) with their prescriber before starting AndroGel. 14
Telehealth TRT Platforms Operating in Ohio
Several national telehealth companies hold prescribing authority in Ohio and can complete the full evaluation-to-prescription workflow remotely (subject to DEA requirements noted above). Typical service models include:
- An online intake questionnaire covering symptoms (using validated tools such as the Androgen Deficiency in Aging Males, or ADAM, questionnaire)
- A lab order sent to a local draw site
- An audio-video visit with a licensed Ohio prescriber once results are back
- Electronic prescribing to a mail-order or local Ohio pharmacy
- Quarterly follow-up labs and asynchronous messaging with the clinical team
Ohio patients in rural counties, such as those in Appalachian Ohio where specialist access is limited, may find telehealth particularly useful. The Ohio Telehealth Program through the Ohio Department of Health has expanded broadband infrastructure to support these visits statewide. 15
The HealthRX clinical team uses the following sequenced eligibility check for Ohio patients requesting AndroGel via telehealth: (1) symptom screen with ADAM questionnaire score of 5 or higher, (2) two morning total testosterone values below 300 ng/dL on LabCorp or Quest panel, (3) PSA below 4.0 ng/mL and hematocrit below 50% on CBC, (4) audio-video prescriber visit confirming no contraindications, (5) electronic prescription sent to patient's preferred Ohio pharmacy or mail-order compounder. Patients who clear all five gates typically receive their first supply within 7 business days of the initial consultation.
Transferring an Existing AndroGel Prescription to Ohio
If you move to Ohio from another state with an active AndroGel prescription, Ohio law and federal DEA regulations require that the prescription be transferred to an Ohio-licensed pharmacy. Schedule III prescriptions may be transferred between pharmacies for the purpose of a single refill under 21 CFR §1306.25. 16
Practically, you will need:
- The original pharmacy name, address, and phone number
- Your prescription number
- The dispensing pharmacist's DEA number
The receiving Ohio pharmacy calls the originating pharmacy and documents the transfer. Because Schedule III prescriptions allow a limited number of refills (maximum five in six months under federal law), the transferred prescription retains its original refill count. Your Ohio prescriber may write a new prescription if refills are exhausted or if dose adjustment is needed.
Cost Reduction Strategies for Ohio Patients
| Option | Estimated Monthly Cost | Notes | |---|---|---| | Brand AndroGel 1.62% (cash) | $450 to $650 | AbbVie co-pay card reduces cost for insured patients | | Brand AndroGel with commercial insurance + PA approval | $30 to $100 co-pay | Varies by plan tier | | Generic testosterone gel 1% (cash, retail) | $80 to $160 | Available at most Ohio pharmacies | | Compounded testosterone gel 10% via 503A (cash) | $60 to $120 | Requires valid Ohio prescription | | NeedyMeds/GoodRx discount pricing | $70 to $200 | Varies by Ohio zip code and pharmacy |
GoodRx and NeedyMeds coupons are accepted at most Ohio retail pharmacies and can reduce the cash price of generic testosterone gel 1% substantially. These discount cards cannot be combined with insurance benefits on the same claim. 17
Safety, Contraindications, and Black Box Warnings
The FDA label for AndroGel carries two Black Box Warnings. First, virilization in children has been reported from secondary exposure to testosterone gel through skin contact or contaminated surfaces. Second, the label warns against use in women, particularly pregnant women, because testosterone causes fetal harm. 1
Absolute contraindications include:
- Known or suspected prostate cancer
- Known or suspected male breast cancer
- Women who are or may become pregnant
- Hypersensitivity to any component of the formulation
Relative contraindications where prescribers exercise individual judgment include:
- Hematocrit above 50% at baseline 5
- Untreated severe obstructive sleep apnea 5
- Uncontrolled heart failure
- Desire for near-term fertility
A 2010 randomized controlled trial by Basaria et al. (TEAM trial, N=209 men aged 65 or older) published in the New England Journal of Medicine reported a higher rate of cardiovascular events in the testosterone group (23 events) compared with placebo (5 events) during a 6-month intervention in men with high baseline cardiovascular risk, leading to early termination of that trial. 18 The FDA subsequently required long-term cardiovascular safety labeling updates. Prescribers in Ohio should review cardiovascular risk at baseline and each follow-up visit.
What to Expect: Timeline from First Inquiry to First Dose
- Day 1. Complete online intake form or schedule in-person appointment. Lab order issued.
- Days 1 to 3. Visit Ohio LabCorp or Quest draw site for testosterone panel and CBC.
- Days 2 to 5. Lab results returned electronically to prescriber platform.
- Days 3 to 7. Audio-video or in-person consultation with Ohio-licensed prescriber.
- Days 4 to 8. Electronic prescription sent to chosen pharmacy. PA initiated with insurer if needed (adds 3 to 15 business days for commercial insurance approval).
- Days 5 to 10. Pharmacy dispenses; local pickup available same day or mail order ships 2-day.
- Day 14. First post-initiation testosterone check (2 hours post-application, morning).
- Week 12. Comprehensive follow-up labs: total testosterone, free testosterone, hematocrit, PSA, estradiol.
Frequently asked questions
›How do I get an AndroGel prescription in Ohio?
›What labs are needed before AndroGel in Ohio?
›Are there telehealth providers in Ohio prescribing AndroGel?
›How long until I receive AndroGel in Ohio?
›Can I transfer an AndroGel prescription to Ohio?
›Are 503A pharmacies in Ohio licensed to ship testosterone gel?
›Who can prescribe AndroGel in Ohio: MD vs NP vs PA?
›What documentation does prior authorization require in Ohio?
References
- AbbVie Inc. AndroGel (testosterone gel) 1.62% prescribing information. U.S. Food and Drug Administration; 2021. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021015s049lbl.pdf
- Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123-135. Available from: https://pubmed.ncbi.nlm.nih.gov/20173018/
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. Available from: https://pubmed.ncbi.nlm.nih.gov/26886521/
- U.S. Drug Enforcement Administration. Controlled substances schedules. Available from: https://www.deadiversion.usdoj.gov/schedules/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. Available from: https://pubmed.ncbi.nlm.nih.gov/29264110/
- Stanworth RD, Jones TH. Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging. 2008;3(1):25-44. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532933/
- Ohio Legislature. Ohio Revised Code §4743.09: Telehealth services. Available from: https://codes.ohio.gov/ohio-revised-code/section-4743.09
- U.S. Drug Enforcement Administration. DEA and telemedicine guidance FAQs. Available from: https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-018)(DEA068)%20DEA%20and%20Telehealth%20Guidance%20FAQs%20%28Final%29+(Signed).pdf
- Ohio Legislature. Ohio Revised Code §4730.10: Physician assistant prescribing authority. Available from: https://codes.ohio.gov/ohio-revised-code/section-4730.10
- AbbVie. myAbbVie Assist patient assistance program. Available from: https://www.abbvie.com/patients/patient-assistance.html
- American Urological Association. Testosterone deficiency guideline. Available from: https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
- Ohio Department of Medicaid. Covered services. Available from: https://medicaid.ohio.gov/resources-for-ohioans/programs/ohio-medicaid/ohio-medicaid-covered-services
- Ohio State Board of Pharmacy. Compounding pharmacy licensing. Available from: https://www.pharmacy.ohio.gov/Licensing/Compounding.aspx
- Crosnoe LE, Grober E, Ohl D, Kim ED. Exogenous testosterone: a preventable cause of male infertility. Transl Androl Urol. 2013;2(2):106-113. Available from: https://pubmed.ncbi.nlm.nih.gov/23482592/
- Ohio Department of Health. Telehealth program. Available from: https://odh.ohio.gov/wps/portal/gov/odh/know-our-programs/telehealth
- U.S. Government Publishing Office. 21 CFR §1306.25: Transfer between pharmacies of prescription information for Schedules III, IV, and V controlled substances for refill purposes. Available from: https://www.ecfr.gov/current/title-21/chapter-II/part-1306/subpart-B/section-1306.25
- NeedyMeds. Drug assistance programs database. Available from: https://www.needymeds.org/
- Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363(2):109-122. Available from: https://pubmed.ncbi.nlm.nih.gov/20592090/